Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FJFS7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,493
Award facts
- Contract value 100% obligated
- $2,492.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,492.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. The delivery order, issued on January 5, 2026, with an ultimate completion date of January 27, 2026, operates under a firm fixed-price structure with no set-aside designation, indicating the award was made through full and open competition. This delivery order is issued under DMS Pharmaceutical Group's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract (SPE2DR), a $499.99 billion prime vendor agreement awarded on November 13, 2025, that positions the company as a critical regional pharmaceutical supplier for Department of Defense military healthcare facilities worldwide through December 31, 2036.
The PPV-G GEN V represents part of a broader $30.3 billion acquisition strategy designed to consolidate pharmaceutical sourcing across the federal military medical system. DMS Pharmaceutical Group has demonstrated substantial federal contracting capability through numerous delivery orders across diverse therapeutic categories, including specialty pharmaceuticals, biologics, vaccines, and medical consumables. As the prime contractor on this delivery order with no identified subcontractors, the company leverages its small business status and established performance record to fulfill recurring pharmaceutical supply needs for Department of Defense operations. The Botox delivery exemplifies the specialized pharmaceutical products supplied through this comprehensive vendor program to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FJFS7?
SPE2DR26FJFS7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FJFS7 worth?
The government has obligated $2,493 on SPE2DR26FJFS7.
Is contract SPE2DR26FJFS7 an order under another contract?
Yes. SPE2DR26FJFS7 is a delivery order under SPE2DR25D9157, an indefinite delivery contract.
Was contract SPE2DR26FJFS7 competed?
The extent of competition for SPE2DR26FJFS7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award